Lazard Asset Management
MXCT icon

Lazard Asset Management’s MaxCyte MXCT Stock Holding History

Lazard Asset Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-284,498
Closed -$620K – 2144
2025
Q2 		$620K Buy
284,498
+137,983
+94% +$334K ﹤0.01% 1440
2025
Q1 		$399K Sell
146,515
-16,980
-10% -$66.9K ﹤0.01% 1467
2024
Q4 		$680K Sell
163,495
-197,955
-55% -$748K ﹤0.01% 1280
2024
Q3 		$1.41M Sell
361,450
-51,448
-12% -$217K ﹤0.01% 966
2024
Q2 		$1.62M Sell
412,898
-54,789
-12% -$236K ﹤0.01% 885
2024
Q1 		$1.96M Buy
467,687
+100,555
+27% +$472K ﹤0.01% 830
2023
Q4 		$1.73M Sell
367,132
-90,236
-20% -$351K ﹤0.01% 875
2023
Q3 		$1.43M Sell
457,368
-13,084
-3% -$52.6K ﹤0.01% 916
2023
Q2 		$2.16M Buy
470,452
+3,322
+0.7% +$15.3K ﹤0.01% 879
2023
Q1 		$2.31M Buy
467,130
+110,069
+31% +$542K ﹤0.01% 890
2022
Q4 		$1.95M Sell
357,061
-128,043
-26% -$785K ﹤0.01% 908
2022
Q3 		$3.15M Buy
485,104
+18,503
+4% +$103K ﹤0.01% 798
2022
Q2 		$2.21M Buy
+466,601
New +$2.3M ﹤0.01% 883

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lazard Asset Management's MXCT Position: Q3 2025 in Review

Lazard Asset Management sold out of MaxCyte (MXCT) in Q3 2025, closing a stake of 284,498 shares — an estimated $620K sold.

Lazard Asset Management first reported a position in MXCT in Q2 2022 and held it in 13 quarters. The position peaked at $3.15M in Q3 2022. 112 funds tracked by Wall St. Rank hold MXCT as of Q3 2025.

  • Lazard Asset Management reported no remaining MaxCyte position as of Q3 2025 after selling out during the quarter.
  • Lazard Asset Management sold 284,498 MaxCyte shares in Q3 2025, an estimated $620K.
  • Lazard Asset Management first reported a position in MaxCyte in Q2 2022 and held it in 13 quarters.
  • Lazard Asset Management's MaxCyte position peaked at $3.15M in Q3 2022.
  • 112 funds tracked by Wall St. Rank held MaxCyte as of Q3 2025.

Based on Lazard Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.